TrianglePUBLICATIONS · 35709415
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Nov 10
- First author
- Hofheinz RD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hofheinz RD
- type
- Author
- name
- Merx K
- type
- Author
- name
- Haag GM
- type
- Author
- name
- Springfeld C
- type
- Author
- name
- Ettrich T
- type
- Author
- name
- Borchert K
- type
- Author
- name
- Kretzschmar A
- type
- Author
- name
- Teschendorf C
- type
- Author
- name
- Siegler G
- type
- Author
- name
- Ebert MP
- type
- Author
- name
- Goekkurt E
- type
- Author
- name
- Mahlberg R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hofheinz RD
- type
- Author
- name
- Merx K
- type
- Author
- name
- Haag GM
- type
- Author
- name
- Springfeld C
- type
- Author
- name
- Ettrich T
- type
- Author
- name
- Borchert K
- type
- Author
- name
- Kretzschmar A
- type
- Author
- name
- Teschendorf C
- type
- Author
- name
- Siegler G
- type
- Author
- name
- Ebert MP
- type
- Author
- name
- Goekkurt E
- type
- Author
- name
- Mahlberg R
- type
- Author
- bibliography ids
- nci-bib-d880c071db627aff56cc1272
- book metadata
- content sha256
- 8ac17d778269fc5d6b413bae7168797db01bc027e9acf940e9cae1658ece0376
- document type
- citation
- dois
- 10.1200/JCO.22.00380
- electronic publication date
- display
- 2022 Jun 16
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35709415
- immutable id
- pubmed:35709415@8ac17d778269fc5d6b413bae7168797db01bc027e9acf940e9cae1658ece0376
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3750-3761
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35709415
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- b0a9b4f41c73390a8290067ede40e9d9066c317201adb637f478c8a2a3419b6a
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Nov 10
- precision
- day
- year
- 2022
- publication types
- Randomized Controlled Trial
- Multicenter Study
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
Preserved source evidence · Not medical advice